imipenem, anhydrous has been researched along with Cat Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bond, GB; Chi, KD; Condas, LAZ; de Farias, MR; de Vargas, AC; Gonoi, T; Matsuzawa, T; Ribeiro, MG; Salerno, T; Siqueira, AK; Werner, J | 1 |
| Álvarez-Pérez, S; Anega, B; Blanco, JL; García, ME; Hernández, M | 1 |
2 other study(ies) available for imipenem, anhydrous and Cat Diseases
| Article | Year |
|---|---|
Molecular identification and antimicrobial resistance pattern of Nocardia isolated from 14 diseased dogs and cats.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Cefuroxime; Dog Diseases; Dogs; Drug Resistance, Bacterial; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Osteomyelitis; RNA, Ribosomal, 16S | 2023 |
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clindamycin; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Diarrhea; Dog Diseases; Dogs; Erythromycin; Fidaxomicin; Humans; Imipenem; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2023 |